ArticleFrontiers in oncology2024

Prevalence of non-Hodgkin lymphoma patients at high-risk of failure after CAR T-cell therapy eligible for bridging radiation therapy.

Adnan Danish et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.